comparemela.com

Page 5 - Canntab Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Canntab Therapeutics signs what it calls an Historic Deal with First Nations to battle opioid Crisis

Canntab Therapeutics CFO Richard Goldstein and CEO Larry Latowsky joined Steve Darling from Proactive to share the company has announced a strategic.

Adam pawisRichard goldsteinLarry latowskyCanntab therapeuticsSteve darlingIndigenous opiateIllicit drug crisisFirst nationsChief adam pawisShawanaga first nation

CANNTAB SIGNS HISTORIC AGREEMENT WITH FIRST NATIONS GROWERS GP INC TO ADDRESS THE OPIATE AND ILLICIT DRUG CRISIS AFFECTING INDIGENOUS PEOPLES THROUGHOUT CANADA

/PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1) (the "Company" or "Canntab"), a leading innovator of cannabinoid and terpene.

Turtle islandBritish columbiaAdam pawisLarry latowskyCompany or canntabCanntab therapeutics limitedCannabis researchFirst nations growers gp incCanntab therapeuticsFrankfurt stock exchangeCanadian securities exchangeHealth canadaTherapeutics limitedIndigenous opiateIllicit drug crisis planFirst nations

CANNTAB ANNOUNCES CLOSING OF CONVERTIBLE DEBENTURE PRIVATE PLACEMENT, WARRANT EXPIRY EXTENSION AND CORPORATE UPDATE

TORONTO, Feb. 1, 2022 /PRNewswire/ Canntab Therapeutics Limited , the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to. | February 2, 2022

United statesRichard goldsteinBarry polisukFirst republic capital corporationCanntab therapeuticsCannabis research licenceFrankfurt stock exchangeCanntab therapeutics limitedUs newswire servicesCompany debenturesNeither the canadian securities exchangeHealth canadaCanadian securities exchangeTherapeutics limitedConversion priceClosing date

CANNTAB OFFICIALLY LAUNCHES ITS ONLINE E-COMMERCE PLATFORM

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene.

Larry latowskyOntario cannabisCanntab therapeutics incHealth canada onCompany or canntabCanntab therapeutics limitedCannabis researchCanntab therapeuticsFrankfurt stock exchangeCanadian securities exchangeTherapeutics limitedMedical sales licenseHealth canadaCannabis standard processingMedical purposes license

CANNTAB OFFICIALLY LAUNCHES ITS ONLINE E-COMMERCE PLATFORM

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene.

Larry latowskyOntario cannabisCanntab therapeutics incHealth canada onCompany or canntabCanntab therapeutics limitedCannabis researchCanntab therapeuticsFrankfurt stock exchangeCanadian securities exchangeTherapeutics limitedMedical sales licenseHealth canadaCannabis standard processingMedical purposes license

vimarsana © 2020. All Rights Reserved.